Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 248

1.

Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas.

Attis MG, Burchette JL, Selim MA, Pham T, Soler AP.

Hum Pathol. 2006 Jul;37(7):899-905. Epub 2006 May 22.

PMID:
16784991
[PubMed - indexed for MEDLINE]
2.

Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.

Kucher C, Zhang PJ, Pasha T, Elenitsas R, Wu H, Ming ME, Elder DE, Xu X.

Am J Dermatopathol. 2004 Dec;26(6):452-7.

PMID:
15618925
[PubMed - indexed for MEDLINE]
3.

Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.

Granter SR, Weilbaecher KN, Quigley C, Fletcher CD, Fisher DE.

Am J Dermatopathol. 2001 Jun;23(3):185-9.

PMID:
11391097
[PubMed - indexed for MEDLINE]
4.

p16 expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma.

Hilliard NJ, Krahl D, Sellheyer K.

J Cutan Pathol. 2009 Jul;36(7):753-9. doi: 10.1111/j.1600-0560.2008.01154.x.

PMID:
19519606
[PubMed - indexed for MEDLINE]
5.

Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression.

Krengel S, Grotelüschen F, Bartsch S, Tronnier M.

J Cutan Pathol. 2004 Jan;31(1):1-7.

PMID:
14675278
[PubMed - indexed for MEDLINE]
6.

Immunohistochemical staining of CD10 in atypical fibroxanthomas.

Hultgren TL, DiMaio DJ.

J Cutan Pathol. 2007 May;34(5):415-9.

PMID:
17448198
[PubMed - indexed for MEDLINE]
7.

Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.

Koch MB, Shih IM, Weiss SW, Folpe AL.

Am J Surg Pathol. 2001 Jan;25(1):58-64.

PMID:
11145252
[PubMed - indexed for MEDLINE]
9.

KBA.62: a useful marker for primary and metastatic melanomas.

Pagès C, Rochaix P, al Saati T, Valmary-Degano S, Boulinguez S, Launay F, Carle P, Lauwers F, Payoux P, Le Guellec S, Brousset P, Lamant L.

Hum Pathol. 2008 Aug;39(8):1136-42. doi: 10.1016/j.humpath.2007.12.006. Epub 2008 May 20.

PMID:
18495211
[PubMed - indexed for MEDLINE]
10.

Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.

Jeschke U, Mylonas I, Kuhn C, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.

Anticancer Res. 2007 Jul-Aug;27(4A):1969-74.

PMID:
17649807
[PubMed - indexed for MEDLINE]
Free Article
11.

Desmoplastic and spindle cell melanomas express protein markers of the neural crest but not of later committed stages of Schwann cell differentiation.

Huttenbach Y, Prieto VG, Reed JA.

J Cutan Pathol. 2002 Oct;29(9):562-8.

PMID:
12358815
[PubMed - indexed for MEDLINE]
12.

Desmoplastic neurotropic melanoma.

Tsao H, Sober AJ, Barnhill RL.

Semin Cutan Med Surg. 1997 Jun;16(2):131-6. Review.

PMID:
9220552
[PubMed - indexed for MEDLINE]
13.

Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma.

Harris GR, Shea CR, Horenstein MG, Reed JA, Burchette JL Jr, Prieto VG.

Am J Surg Pathol. 1999 Jul;23(7):786-94.

PMID:
10403301
[PubMed - indexed for MEDLINE]
14.

Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.

Bauer R, Wild PJ, Meyer S, Bataille F, Pauer A, Klinkhammer-Schalke M, Hofstaedter F, Bosserhoff AK.

J Clin Pathol. 2006 Jul;59(7):699-705. Epub 2006 Mar 24.

PMID:
16565225
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases.

Anstey A, Cerio R, Ramnarain N, Orchard G, Smith N, Jones EW.

Am J Dermatopathol. 1994 Feb;16(1):14-22.

PMID:
7512798
[PubMed - indexed for MEDLINE]
16.

Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.

de Almeida LS, Requena L, Rütten A, Kutzner H, Garbe C, Pestana D, Gomes MM.

Am J Dermatopathol. 2008 Jun;30(3):207-15. doi: 10.1097/DAD.0b013e3181716e6b.

PMID:
18496419
[PubMed - indexed for MEDLINE]
17.

Cytoplasmic expression of nm23 predicts the potential for cerebral metastasis in patients with primary cutaneous melanoma.

Sarris M, Scolyer RA, Konopka M, Thompson JF, Harper CG, Lee CS.

Melanoma Res. 2004 Feb;14(1):23-7. Erratum in: Melanoma Res. 2004 Jun;14(3):239. Lee, Soon C [corrected to Lee, C Soon].

PMID:
15091190
[PubMed - indexed for MEDLINE]
18.

SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.

Ramos-Herberth FI, Karamchandani J, Kim J, Dadras SS.

J Cutan Pathol. 2010 Sep;37(9):944-52. doi: 10.1111/j.1600-0560.2010.01568.x.

PMID:
20653825
[PubMed - indexed for MEDLINE]
19.

Expression of p53 protein in melanoma progression.

Kanoko M, Ueda M, Nagano T, Ichihashi M.

J Dermatol Sci. 1996 Jun;12(2):97-103.

PMID:
8814540
[PubMed - indexed for MEDLINE]
20.

MMP-21 is upregulated at early stages of melanoma progression but disappears with more aggressive phenotype.

Kuivanen T, Ahokas K, Virolainen S, Jahkola T, Hölttä E, Saksela O, Saarialho-Kere U.

Virchows Arch. 2005 Dec;447(6):954-60. Epub 2005 Aug 20.

PMID:
16133364
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk